health

• Global Industry Partners Jointly Release Net5.5G Best Practices & Deployment Guide Whitepaper

  

  BARCELONA,Spain,March 5,2025-- At MWC Barcelona 2025,the Broadband Development Congress (BDC),hosted by the WBBA,was a resounding success. Themed "Smarter Broadband: Investment. Innovation. Intel

  03-06

  Details

• CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination with First-Line Standard-of-Care for DLBCL

  

  PhaseIb trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL),aiming to reshape the standard-of-care landscape.

  03-06

  Details

• Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma

  

  HONG KONG,March 6,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical tria

  03-06

  Details

• MOBILE OPERATORS ACCOUNT FOR 85% OF INVESTMENTS IN MOBILE INTERNET CONNECTIVITY INFRASTRUCTURE, NEW GSMA REPORT REVEALS

  

  Governments should prioritise pro-investment policies to accelerate network expansion and strengthen digital economies

  03-05

  Details

• AXA Climate School nurtures young talents in Hong Kong

  

  Empowering future leaders with essential skills to combat climate change HONG KONG,March 3,2025-- AXA Hong Kong and Macau("AXA") launched the AXA Climate School in 2022,aimingto empower youn

  03-05

  Details

• Unleashing Swarm Intelligence: UBTECH Pioneers the World's First Multi-Humanoid Robot Collaborative Training in Multi-Task, Multi-Scenario Settings at ZEEKR

  

  SHENZHEN,China,March 3,2025-- UBTECH has successfully conducted the world\'s first collaborative practical training program for humanoid robots at ZEEKR\'s 5G Intelligent Factory,where multiple humano

  03-05

  Details

• Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics

  

  First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat (IBZ) to other anti-CDI antibiotics in a germ-free mouse model

  03-05

  Details

• Transforming Tianhe: A Vision for Modern Industries

  

  BEIJING,March 3,2025-- A news report fromchinadaily.com.cn： A panoramic view of the skyscrapers of Tianhe district. [Photo/VCG]

  03-05

  Details

• SunCar Partners with Visa to Empower ICBC Cardholder Benefits in China's Affluent Consumer Market

  

  NEW YORK,March 3,2025-- SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ: SDA),an innovative leader in auto e-insurance and cloud-based B2B auto services in China,t

  03-05

  Details

• Tantech Holdings Regains Compliance with NASDAQ Minimum Bid Price Requirement

  

  LISHUI,China,March 3,2025-- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company") announced today that on February 28,2025,it received notification from The Nasdaq Stock

  03-05

  Details